Work

Prostate Cancer Cells With the AR‐Low and EMT‐High Phenotype Are Vulnerable to NAD+ Synthesis Inhibitors

Year: 2025

Type: article

Source: The Prostate

DOI: 10.1002/pros.70100

Authors: Hyun‐Kyung Ko, Rebecca L. Foertsch, Kasen Shi, Janét Pittsenbarger, Changhui Xue, Kaiyo Shi, Hao Geng, Lina Gao, David Z. Qian

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: Adaptive resistance to HIF1a inhibition in hypoxia, HIF1a N-terminus hyperacetylation and anticancer mechanism of hydroxamic-HDACi

OpenAlex ID: W4417231033

FWCI: 0.587

Cites: 48

Cited by: 1

Related to: